Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer’s Disease - Cohen, S; van Dyck, C H; Gee, M (J Prev Alzheimers Dis, 2023)